You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Alemtuzumab

Showing 26 - 50 of 419
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis Trial in Ramat Gan (COVID-19 vaccination)

Recruiting
  • Multiple Sclerosis
  • COVID-19 vaccination
  • Ramat Gan, Israel
    Sheba Medical Center
Oct 6, 2021

Neurofilaments for NEDA Assessing in MS

Terminated
  • Multiple Sclerosis
  • Alemtuzumab
  • London, England, United Kingdom
    Queen Mary University of London
Feb 9, 2022

Acute Undifferentiated Leukemia, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia Trial

Completed
Has Results
  • Acute Undifferentiated Leukemia
  • +13 more
  • Chicago, Illinois
    Cancer and Leukemia Group B
Apr 5, 2022

Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)

Active, not recruiting
  • Chronic Granulomatous Disease Transplant
  • Alemtuzumab
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 21, 2023

Alemtuzumab Treated Multiple Sclerosis Patients

Completed
  • Multiple Sclerosis
    • Gatineau, Quebec, Canada
      Clinique Neuro-Outaouais
    Jul 27, 2021

    Sickle Cell Anemia, Beta Thalassemia Trial run by the NHLBI (radiation, drug, biological)

    Recruiting
    • Sickle Cell Anemia
    • Beta Thalassemia
    • TBI
    • +6 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Congenital Hemolytic Anemia, Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Peripheral

    Recruiting
    • Congenital Hemolytic Anemia
    • Sickle Cell Disease
    • Peripheral blood hematopoietic progenitor cell (PBPC) transplant
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    End-stage Renal Failure, Graft Rejection Trial in London (Tacrolimus (Kidney transplant maintenance immunosuppression), Kidney

    Completed
    Has Results
    • End-stage Renal Failure
    • Graft Rejection
    • Tacrolimus (Kidney transplant maintenance immunosuppression)
    • Kidney transplant maintenance immunosuppression
    • London, United Kingdom
      West London Renal & Transplant Centre, Hammersmith Hospital
    Aug 26, 2021

    Progressive Multiple Sclerosis Trial in Barcelona (Acyclovir, Methylprednisolone, alemtuzumab GZ402673)

    Completed
    • Progressive Multiple Sclerosis
    • Barcelona, Spain
      Investigational Site Number 724001
    Mar 8, 2021

    Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases Trial run by the NCI (drug, radiation,

    Recruiting
    • Lymphoproliferative Disorders
    • +4 more
    • Busulfan test dose
    • +8 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    B-cell Non-Hodgkin Lymphoma (B-NHL) Trial in Austin (UCART20x22, CLLS52)

    Recruiting
    • B-cell Non-Hodgkin Lymphoma (B-NHL)
    • UCART20x22
    • CLLS52
    • Austin, Texas
      Sarah Cannon - St. David South Austin Medical Center
    Dec 8, 2022

    Hemophagocytic Lymphohistiocytosis (HLH) Trial in Paris (Alemtuzumab, Methyl Prednisolone (MP), Cyclosporin A (CSA))

    Completed
    • Hemophagocytic Lymphohistiocytosis (HLH)
    • Alemtuzumab
    • +2 more
    • Paris, France
      Hôpital Necker-Enfants Malades
    Apr 13, 2021

    Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

    Recruiting
    • Sickle Cell Disease
    • +3 more
    • Alemtuzumab
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,

    Recruiting
    • Primary Immune Deficiency Disorder
    • +2 more
    • Alemtuzumab
    • +6 more
    • Baltimore, Maryland
      Johns Hopkins University
    Oct 20, 2022

    Sickle Cell Disease Trial in Saint Louis (drug, radiation, procedure)

    Terminated
    • Sickle Cell Disease
    • Alemtuzumab
    • +6 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 28, 2022

    Relapsing-remitting Multiple Sclerosis Trial in Stockholm (Rituximab)

    Active, not recruiting
    • Relapsing-remitting Multiple Sclerosis
    • Stockholm, Sweden
      Fredrik Piehl
    Apr 8, 2022

    Sickle Cell Disease Trial in Chicago (Allogeneic Non-Myeloablative Stem Cell Transplantation, Alemtuzumab, Sirolimus)

    Recruiting
    • Sickle Cell Disease
    • Allogeneic Non-Myeloablative Stem Cell Transplantation
    • +2 more
    • Chicago, Illinois
      University of Illinois at Chicago
    Feb 16, 2022

    Renal Transplantation Trial in United States (Alemtuzumab, rabbit antithymocyte globulin, Belatacept)

    Completed
    Has Results
    • Renal Transplantation
    • Alemtuzumab
    • +5 more
    • San Francisco, California
    • +7 more
    Jul 8, 2021

    Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia Trial in

    Active, not recruiting
    Has Results
    • Stage I Chronic Lymphocytic Leukemia
    • +3 more
    • alemtuzumab
    • +2 more
    • Chicago, Illinois
    • +1 more
    Dec 29, 2020

    Kidney Transplantation, Kidney Diseases, Kidney Failure Trial in London (Campath, Daclizumab)

    Completed
    Has Results
    • Kidney Transplantation
    • +2 more
    • London, United Kingdom
      West London Renal and Transplant Centre, 4th Floor Ham House, Ha
    Sep 1, 2021

    Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia Trial in Pittsburgh (CD3/CD19 depleted leukocytes, CD45RA

    Recruiting
    • Sickle Cell Anemia
    • +2 more
    • CD3/CD19 depleted leukocytes
    • +6 more
    • Pittsburgh, Pennsylvania
      Children's Hospital of Pittsburgh of UPMC
    May 4, 2022

    Leukemia Trial in Chicago (Alemtuzumab, Rituximab)

    Completed
    Has Results
    • Leukemia
    • Alemtuzumab
    • Rituximab
    • Chicago, Illinois
      Northwestern University, Northwestern Medical Faculty Foundation
    Oct 15, 2020

    Sickle Cell Disease Trial in Canada, United States (Alemtuzumab intravenously, low dose total body irradiation, Sirolimus)

    Recruiting
    • Sickle Cell Disease
    • Alemtuzumab intravenously, low dose total body irradiation, Sirolimus
    • Washington, District of Columbia
    • +5 more
    Mar 2, 2022

    Novel Peri Infusion Regimen on Infusion Associated Reactions

    Active, not recruiting
    • Frequency of Infusion Reactions in Novel Versus Standard Protocol in Multiple Sclerosis
    • Alemtuzumab Injection
    • Halifax, Nova Scotia, Canada
      Maritime Neurology
    Nov 11, 2020

    Sickle Cell Disease, Beta Thalassemia Trial in New York (Busulfan, Fludarabine, Alemtuzumab)

    Active, not recruiting
    • Sickle Cell Disease
    • Beta Thalassemia
    • New York, New York
      Morgan Stanley Children's Hospital, New York-Presbyterian, Colum
    Aug 12, 2021